Donor-derived cell-free DNA (dd-cfDNA) is a non-invasive biomarker that permits early diagnosis of antibody-mediated rejection (AMR) in kidney transplant recipients with de novo anti-HLA donor ...

More information: Hua Bao et al, Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics, Nature Medicine (2025). DOI: 10.1038/s41591-025-03735-2 ...

Akifova A, Budde K, Amann K, et al. Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial. Nephrol Dial Transplant.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its Prospera Lung test has met coverage requir ...